Cero Therapeutics announces progress in initiation of Phase 1 trial
PremiumThe FlyCero Therapeutics announces progress in initiation of Phase 1 trial
29d ago
Cero Therapeutics reports current cash position of $8M
Premium
The Fly
Cero Therapeutics reports current cash position of $8M
2M ago
Cero Therapeutics prices $5M at-the-market offering
Premium
The Fly
Cero Therapeutics prices $5M at-the-market offering
2M ago
Cero Therapeutics files to sell common stock, warrants, no amount given
PremiumThe FlyCero Therapeutics files to sell common stock, warrants, no amount given
3M ago
CERo Therapeutics Appoints New CEO to Lead Innovations
Premium
Company Announcements
CERo Therapeutics Appoints New CEO to Lead Innovations
4M ago
Cero Therapeutics appoints Chris Ehrlich as CEO
Premium
The Fly
Cero Therapeutics appoints Chris Ehrlich as CEO
4M ago
3 Penny Stocks to Watch Now, 11/14/24
PremiumMarket News3 Penny Stocks to Watch Now, 11/14/24
5M ago
CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data
Premium
Market News
CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data
5M ago
Cero Therapeutics presents preclinical data on CER-1236
Premium
The Fly
Cero Therapeutics presents preclinical data on CER-1236
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100